Covestor Ltd
- SEC CIK
- 0001909846
- Latest filing
- Aug 7, 2026
EGRX holding history
Eagle Pharmaceuticals, Inc. in every 13F filed by Covestor Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EGRX overviewAll 13F holders of EGRXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −116−100.0% | Sold out | Holders |
| Q4 2023 | 116 | $1.00K | <0.1% | +31+36.5% | Added | Holders |
| Q3 2023 | 85 | $1.00K | <0.1% | +23+37.1% | Added | Holders |
| Q2 2023 | 62 | $1.00K | <0.1% | +18+40.9% | Added | Holders |
| Q1 2023 | 44 | $1.00K | <0.1% | −21−32.3% | Reduced | Holders |
| Q4 2022 | 65 | $2.00K | <0.1% | +46+242.1% | Added | Holders |
| Q3 2022 | 19 | $1.00K | <0.1% | +19 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −111−100.0% | Sold out | Holders |
| Q1 2022 | 111 | $6.00K | <0.1% | +66+146.7% | Added | Holders |
| Q4 2021 | 45 | $2.00K | <0.1% | – | No prior filing | Holders |